Physician profile
Aaron Grober
NPI 1174917041
$6,854.05
in general payments reported to CMS, 2019-2025
24 companies · $1,472 in 2025
The $1,472 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.72 · 2020: $72.85 · 2021: $161 · 2022: $962 · 2023: $1,522 · 2024: $2,613 · 2025: $1,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,756 · Travel and Lodging: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,755.96 |
| Travel and Lodging | $850.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,891.04 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shockwave Medical, INC | $1,481.90 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $1,223.46 | 2019-2025 | Synergy, Comet, Stingray |
| Abiomed | $722.62 | 2022-2025 | Impella |
| Abbott Laboratories | $585.67 | 2020-2025 | Assurity, Mitraclip, Dragonfly Opstar |
| Medtronic, INC. | $160.52 | 2021 | |
| Amgen INC. | $144.39 | 2024-2025 | Repatha, Repatha |
| Penumbra, INC. | $124.45 | 2024 | Indigo System |
| Merck Sharp & Dohme LLC | $104.73 | 2024 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $55.87 | 2023-2024 | Lifevest |
| Pfizer INC. | $55.75 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.53 | 2025 | |
| Novartis Pharmaceuticals Corporation | $45.42 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $32.27 | 2024 | Arcalyst |
| Cordis US Corp. | $21.69 | 2025 | Mynx Control |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $20.92 | 2024 | Zio Monitor, Zio Xt Patch |
| Cathworks, INC. | $20.49 | 2019 | |
| Acist Medical Systems, INC. | $18.68 | 2023 | |
| Novo Nordisk INC | $18.12 | 2024 | Ozempic |
| Inspire Medical Systems, INC. | $16.75 | 2023 | Inspire |
| Scpharmaceuticals INC. | $16.23 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.25 | 2024 | Xarelto |
| Teleflex LLC | $13.75 | 2023 | Guideliner |
| Stryker Corporation | $13.55 | 2025 | Flowtriever |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Grober listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.